Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany
Authors:
- Ralf René ReinertRRRalf René Reinert
- Adnan Al-LahhamAAAdnan Al-Lahham
- Maria LemperleMLMaria Lemperle
- Christoph TenholteCTChristoph Tenholte
- Claudia BriefsCBClaudia Briefs
- Stefan HauptsSHStefan Haupts
- Hans Hubert GerardsHGHans Hubert Gerards
- Rudolf LüttickenRLRudolf Lütticken
Open Access
- 1 January 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 49 (1) , 61-68
Abstract
Continuous nationwide surveillance of antibiotic resistance in invasive pneumococcal disease was performed in Germany between 1992 and 2000, with a total of 2586 strains being isolated. The average resistance rates to erythromycin and clindamycin were 7.7% and 3.5%, respectively, throughout the study period; 3.3% of strains were found to have intermediate resistance to penicillin. Over the study period an increase in both macrolide and penicillin resistance was observed. The percentage of strains exhibiting reduced susceptibility to penicillin increased from 1.8% in 1992 to 5.8% in 2000. A dramatic increase in resistance was observed with erythromycin, where the resistance rate rose from 3.0% in 1992 to 15.3% in 2000. Of the erythromycin-resistant strains, 86 (43.4%) and 111 (56.1%) belonged to the erm(B) and mef types of resistance, respectively. An analysis of macrolide consumption data during the study period showed that erythromycin resistance was highly correlated to the consumption of newer bd and od macrolides (r = 0.89, P < 0.01).Keywords
This publication has 19 references indexed in Scilit:
- Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997)Journal of Antimicrobial Chemotherapy, 2000
- Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and ClarithromycinClinical Infectious Diseases, 2000
- Proportion of Invasive Pneumococcal Infections in German Children Preventable by Pneumococcal Conjugate VaccinesClinical Infectious Diseases, 2000
- Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998Journal of Antimicrobial Chemotherapy, 2000
- Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolatesJournal of Antimicrobial Chemotherapy, 2000
- Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in ItalyJournal of Antimicrobial Chemotherapy, 1999
- Impact of Antibiotic Resistance on Chemotherapy for Pneumococcal InfectionsMicrobial Drug Resistance, 1998
- Antibiotikaempfindlichkeit wichtiger Erreger bakterieller Atemwegsinfektionen im Nordosten DeutschlandsMedizinische Klinik, 1998
- Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, SpainNew England Journal of Medicine, 1995
- Capsular types and antibiotic susceptibility ofStreptococcus pneumoniae isolated from patients with systemic infections in West GermanyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987